ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,035.69
      -1.57%
      US Tech 100
      16,898.80
      -0.50%
      Dow Jones
      37,815.92
      -1.49%
      Brent Oil
      85.375
      -0.61%
      Bitcoin
      56,928.57
      -6.06%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Dare Bioscience Inc (DARE)

      7. Dare Bioscience Inc (DARE) News

      DARE

      Dare Bioscience (DARE)

      Dare Bioscience Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:DARE
      DateTimeSourceHeadlineSymbolCompany
      12:53PMiHub NewswireFeaturedCannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia
      04/30/20247:30AMGlobeNewswire Inc.Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates through Key CatalystsNASDAQ:DAREDare Bioscience Inc
      04/23/20248:00AMGlobeNewswire Inc.Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1NASDAQ:DAREDare Bioscience Inc
      04/11/20248:00AMGlobeNewswire Inc.Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal ContraceptiveNASDAQ:DAREDare Bioscience Inc
      03/28/20248:00AMGlobeNewswire Inc.Daré Bioscience Reports Full Year 2023 Financial Results and Provides Company UpdateNASDAQ:DAREDare Bioscience Inc
      03/28/20247:42AMIH Market NewsUS Stock Futures Stable in Pre-Market On Path for Consecutive Quarterly Gains, Oil Prices RiseNASDAQ:DAREDare Bioscience Inc
      03/21/20248:00AMGlobeNewswire Inc.Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024NASDAQ:DAREDare Bioscience Inc
      02/22/20248:00AMGlobeNewswire Inc.Daré Bioscience to Present at the International Society for the Study of Women’s Sexual Health (ISSWSH) Annual MeetingNASDAQ:DAREDare Bioscience Inc
      01/31/20248:00AMGlobeNewswire Inc.Daré Bioscience Announces Positive End-of-Phase 2 Meeting with FDA on Development of Sildenafil Cream, 3.6% in Female Sexual Arousal Disorder and Provides Company Focus Areas for 2024NASDAQ:DAREDare Bioscience Inc
      01/29/20244:18PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DAREDare Bioscience Inc
      01/26/20245:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAREDare Bioscience Inc
      01/26/20244:30PMGlobeNewswire Inc.Daré Bioscience Announces Executive Team and Board of Directors ChangesNASDAQ:DAREDare Bioscience Inc
      01/19/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAREDare Bioscience Inc
      01/17/20248:00AMGlobeNewswire Inc.Daré Bioscience Announces Grant to Support Biotherapeutic Product DevelopmentNASDAQ:DAREDare Bioscience Inc
      01/08/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAREDare Bioscience Inc
      01/04/20248:00AMGlobeNewswire Inc.Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s Health as well as in Treating a Broad Range of DiseasesNASDAQ:DAREDare Bioscience Inc
      12/26/20234:05PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:DAREDare Bioscience Inc
      12/26/20238:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAREDare Bioscience Inc
      12/26/20238:00AMGlobeNewswire Inc.Daré Bioscience Secures $12 million in Royalty-backed Investment StructureNASDAQ:DAREDare Bioscience Inc
      12/20/20238:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAREDare Bioscience Inc
      12/20/20238:00AMGlobeNewswire Inc.Daré Bioscience Announces Positive Topline Pharmacokinetic and Exploratory Efficacy Results from the DARE-PDM1 Phase 1 Clinical StudyNASDAQ:DAREDare Bioscience Inc
      12/13/20238:00AMGlobeNewswire Inc.Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Support DARE-PTB1 Phase 1 Human Clinical StudyNASDAQ:DAREDare Bioscience Inc
      12/07/20238:00AMGlobeNewswire Inc.Daré Bioscience Announces FDA Clearance of Investigational New Drug (IND) Application for DARE-VVA1, a Novel Intravaginal Formulation of Tamoxifen for Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy Associated with MenopauseNASDAQ:DAREDare Bioscience Inc
      12/04/20238:00AMGlobeNewswire Inc.Daré Bioscience Announces Commencement of Phase 3 Study of Ovaprene®, an Investigational Hormone-Free Monthly Intravaginal ContraceptiveNASDAQ:DAREDare Bioscience Inc
      11/20/20238:00AMGlobeNewswire Inc.Daré Bioscience and Premier Research Extend Strategic Partnership to Accelerate the Clinical Development of Daré’s Novel Women’s Health ProgramsNASDAQ:DAREDare Bioscience Inc
      11/13/20238:00AMGlobeNewswire Inc.Daré Bioscience to Present at the Sexual Medicine Society of North America (SMSNA) 24th Annual Fall Scientific MeetingNASDAQ:DAREDare Bioscience Inc
      11/09/20235:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAREDare Bioscience Inc
      11/09/20234:02PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DAREDare Bioscience Inc
      11/09/20238:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAREDare Bioscience Inc
      11/09/20238:00AMGlobeNewswire Inc.Daré Bioscience Reports Third Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:DAREDare Bioscience Inc
       Showing the most relevant articles for your search:NASDAQ:DARE